A malignant bone process is more likely to be 1 or more metastasis than a primary bone cancer, and more bone mets are (osteo)lytic than osteoblastic (or sclerotic). Lytic bone lesions arise when tumor cells from a primary tumor in a different part of the body are deposited in the vascular beds of the bone matrix and grow with the help of parathyroid hormone-related peptide (PTHrP) stimulating osteoclasts to chew up existing bone. Sclerotic bone mets lead to more bone deposition through an uncertain mechanism. Both are seen better on CT or MRI than on plain xrays; sclerotic lesions are seen better than lytic ones on nuclear medicine scans (bone scintigraphy or PET-CT).
Pro-Tip: A single primary malignancy can lead to mixed lytic and sclerotic lesions.
Lytic lesion: Puyó Vera D, Renal cell carcinoma with metastases to the bony pelvis. Case study, Radiopaedia.org (Accessed on 20 Oct 2025) https://doi.org/10.53347/rID-29355
Sclerotic lesions: Niknejad M, Diffuse osteoblastic metastasis. Case study, Radiopaedia.org (Accessed on 20 Oct 2025) https://doi.org/10.53347/rID-84377















